LONDON (Reuters) – Britain is close to a supply agreement of 500 million pounds ($ 624 million) with Sanofi and GlaxoSmithKline for 60 million doses of a possible COVID-19 vaccine, the Sunday Times reported. FILE PHOTO: A small bottle labeled with a “Vaccine” label stands near a medical syringe in …
Read More »
GENEVA (Reuters) – Nearly 30% of genome sequencing data from samples of the COVID-19 virus collected by the World Health Organization (WHO) have shown signs of mutation, but there is no evidence that this has led to a more serious illness. The WHO official said Friday. “I think it is …
Read More »
MUMBAI (Reuters) – India’s leading clinical research agency said on Saturday that its decision to accelerate the development of a possible coronavirus vaccine was in line with international standards, after health experts expressed concern about the clinical trial schedule. FILE PHOTO: Small bottles labeled with “Vaccine” stickers are placed near …
Read More »
Moderna’s shares fell nearly 5% ahead of Thursday’s long holiday weekend, after a Stat report said biotechnology would have to delay the start of its main phase 3 pandemic vaccine trial. Shares fell as much as 10% on Thursday before the end of the day with a 4.9% drop, increasing …
Read More »
As the coronavirus pandemic continues worldwide, there has been a fight to release a safe and effective vaccine. More than 140 candidate vaccines have been developed globally, and 18 of them are currently in human trials. Vaccine trials generally undergo three rounds of testing: phase 1, phase 2, and phase …
Read More »